Microport
Microport
Microport mainly engages in medical research and medical equipment production.
MicroPort, established in 1998, is a medical device manufacturer. The company's products cover ten major fields, such as implants, orthopedic medical devices, aortic and puncture vascular intervention products, electrophysiological medical devices and nerve implant products. Founded by Chang Yaohua, it went public on the Hong Kong Stock Exchange. The shareholders are Otsuka, Maxwell Maxcare Science, Shanghai ZJ Hi-Tech Investment, Starwick Investments. Microport's direct competitors include Lepu Medical and Weigao.
- All
- News
- Analysis
- Research
Briefing Nov 26, 2021 09:41 AM
· Healthcare
Longhui medical completed nearly 100 million yuan of round B financing, and Shanlan capital and Sinopharm capital jointly led the investment
Briefing Nov 26, 2021 09:32 AM
· Healthcare
Yueying technology completed hundreds of millions of yuan of a + round financing and deeply cultivated heart brain computing medicine
In depth
Briefing Nov 02, 2021 05:08 PM
· Healthcare
Shu Rui announced the completion of B + financing and the exclusive strategic investment of Medtronic
Briefing Oct 30, 2021 10:44 AM
· Healthcare
Minimally invasive group investment holding Argus strengthens the multi-dimensional layout of precision medicine in the pan vascular field
Apr 22, 2021 03:11 PM
Research
Healthcare, Technology, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Aug 09, 2020 12:23 AM
Briefing Sep 30, 2021 02:41 PM
· Healthcare
AstraZeneca acquires Caelum Biosciences overweight rare diseases business
Briefing Sep 27, 2021 11:57 AM
· Healthcare
Triarm therapeutics completed a round of financing of US $60 million
Briefing Sep 15, 2021 09:15 AM
· Healthcare
Huihe medical completed round B + financing and focused on building a whole industry platform for cardiovascular intervention
Briefing Sep 13, 2021 09:21 AM
· Healthcare
Xushui Internet obtained tens of millions of yuan pre-A round of financing to accelerate the research and development of medical equipment aiot and digital applications
Insight
Briefing Aug 31, 2021 05:29 PM
· Healthcare
Dashi pharmaceutical completed a round of financing of nearly 100 million yuan
Briefing Aug 31, 2021 01:54 PM
· Healthcare
Shanghai Songli biology led the formulation of ASTM International Standards for the first time
Briefing Aug 30, 2021 10:24 AM
· Healthcare
Xinhua biological vibrantfold can accurately predict the antibody structure in 1 minute
Healthcare
Sinopharm COVID Vaccine Receives WHO Emergency Use Certification
The Sinopharm Group’s COVID Vaccine is the sixth vaccine to receive safety, efficacy and quality verification from the World Health Organization (WHO). It is the first vaccine from a non-Western country to receive WHO certification.
May 11, 2021 03:35 AM
Briefing Aug 18, 2021 09:37 AM
· Healthcare
Yiying medical obtained 65 million yuan of a + round financing to accelerate the expansion of intraoperative 3D imaging equipment product line
Briefing Dec 11, 2020 09:57 PM
· Healthcare
Minimally invasive medical treatment: considering the separation of minimally invasive medical robot and independent listing
Briefing Updated 12 hours ago
· Healthcare
2021 Chinese hospital internet influence ranking list released 127 hospitals in 17 provinces and cities
See more
Related Companies
EqualOcean Analysis
- Black Swans and Breakthroughs: China's Top 50 Innovative Public Firms in 2020
- More Room for the Medical Device Market to Grow in China
- Chinese CT Big Brother Neusoft Eyes the Booming Star Market
- Top 10 Market Cap Chinese Medical Device Companies: Champions and Runners-Up
- YuYue Medical Devices: Not Too Late to Focus on R&D
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.